Virginia Retirement Systems’s Viridian Therapeutics VRDN Stock Holding History

Virginia Retirement Systems’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+11,100	New	+$179K	﹤0.01%	1256
2026 Q1	–	Sell	-10,100	Closed	-$314K	–	1066
2025 Q4	$314K	Buy	+10,100	New	+$277K	﹤0.01%	840
2025 Q3	–	Sell	-12,900	Closed	-$180K	–	1060
2025 Q2	$180K	Sell	12,900 -5,300	-29%	-$71.9K	﹤0.01%	905
2025 Q1	$245K	Buy	+18,200	New	+$310K	﹤0.01%	924

Other funds holding VRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Virginia Retirement Systems's VRDN Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Viridian Therapeutics (VRDN) in Q2 2026: 11,100 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1256 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in VRDN as recently as Q4 2025.

Virginia Retirement Systems first reported a position in VRDN in Q1 2025 and has held it in 4 quarters since. The position peaked at $314K in Q4 2025. 214 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

Virginia Retirement Systems held 11,100 shares of Viridian Therapeutics worth $204K as of Q2 2026.
Viridian Therapeutics was a new Virginia Retirement Systems position in Q2 2026.
Viridian Therapeutics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1256 holding.
Virginia Retirement Systems first reported a position in Viridian Therapeutics in Q1 2025 and has held it in 4 quarters since.
Virginia Retirement Systems's Viridian Therapeutics position peaked at $314K in Q4 2025.
214 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.